Astrana Health (NASDAQ:ASTH – Get Free Report) was upgraded by Baird R W to a “strong-buy” rating in a research report issued to clients and investors on Thursday, Zacks.com reports. ASTH has been the topic of several other reports. Truist Financial upped their target price on Astrana Health from $41.00 to $44.00 and gave the […]
Astrana Health, Inc. Forecasted to Earn Q2 2024 Earnings of $0.40 Per Share (NASDAQ:ASTH) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Astrana Health (NASDAQ:ASTH) Price Target Cut to $45.00 by Analysts at Stifel Nicolaus themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Astrana Health (NASDAQ:ASTH – Get Free Report) announced its quarterly earnings data on Tuesday. The company reported $0.26 earnings per share for the quarter, beating analysts’ consensus estimates of $0.17 by $0.09, Briefing.com reports. The firm had revenue of $353.00 million during the quarter, compared to analysts’ expectations of $341.17 million. Astrana Health had a […]
Astrana Health (NASDAQ:ASTH) Announces Quarterly Earnings Results, Beats Estimates By $0.09 EPS themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Astrana Health (NASDAQ:ASTH) Announces Earnings Results, Beats Estimates By $0.09 EPS theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Astrana Health (NASDAQ:ASTH – Get Free Report) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share (EPS) guidance of $1.28-$1.52 for the period, compared to the consensus estimate of $1.52. The company issued revenue guidance of $1.650-$1.850 billion, compared to the consensus revenue estimate of $1.74 billion. […]